Photochemistry and Photobiology 2004-01-01

Primary photochemical processes of the phototoxic neuroleptic cyamemazine: a study by laser flash photolysis and steady-state irradiation.

Patrice Morlière, Francisco Bosca, Miguel A Miranda, José V Castell, René Santus

Index: Photochem. Photobiol. 80(3) , 535-41, (2004)

Full Text: HTML

Abstract

The photophysical and photochemical properties of the UV-A-absorbing phototoxic drug cyamemazine (CMZ) (2-cyano-10-(3-[dimethylamino]-2-methyl-propyl)-phenothiazine) have been investigated in neutral buffered aqueous solutions. The transient absorbances of the hydrated electrons, of the first excited triplet state (3CMZ*) with a characteristic absorption band peaking at 420 nm and of the radical cation (*CMZ+) (maximum absorbance at 500 nm) have been observed by 355 nm laser flash spectroscopy of deaerated solutions. All these transient species are formed by monophotonic processes and react with oxygen. Bimolecular reaction rate constants of *CMZ+ and 3CMZ* with O2 are 2 x 10(7) M(-1) s(-1) and 4 x 10(9) M(-1) s(-1), respectively. The 3CMZ* reacts only sluggishly (reaction rate constant, 9 x 10(6) M(-1) s(-1)) with tryptophan chosen as a Type-I photodynamic substrate. Steady-state irradiations with 365 nm light demonstrate that CMZ is rapidly photolyzed (quantum yield, 0.04) in O2-saturated solutions leading to oxidation of the sulfur atom and of the side-chain nitrogen of CMZ. This photoproduct (2-cyano-10-(3-[dimethylamino, N-oxide]-2-methyl-propyl)-5-oxide-phenothiazine), is a good Type-I and Type-II photodynamic photosensitizer producing singlet oxygen in high yield (approximately 0.45) and could play a major role in the phototoxicity of CMZ.


Related Compounds

  • Cyamemazine

Related Articles:

Identification and quantification of 35 psychotropic drugs and metabolites in hair by LC-MS/MS: application in forensic toxicology.

2015-03-01

[Int. J. Legal Med. 129(2) , 259-68, (2015)]

Fatal intoxication with milnacipran

2008-01-01

[J. Forensic Leg. Med. 15(6) , 388-90, (2008)]

Prise en charge médicamenteuse de l’anxiété chez le patient souffrant de schizophrénie

2011-01-01

[Encephale 37 Suppl 1 , S83-9, (2011)]

Characterization of human cytochrome P450 enzymes involved in the metabolism of cyamemazine.

2007-12-01

[Eur. J. Pharm. Sci. 32(4-5) , 357-66, (2007)]

Potential role of cortical 5-HT(2A) receptors in the anxiolytic action of cyamemazine in benzodiazepine withdrawal.

2012-07-30

[Psychiatry Res. 198(2) , 307-12, (2012)]

More Articles...